Government ContextGovernment Context
DocumentsDocuments by topicDocuments by agencyPricingLog inCreate account
Nonrulemaking

Requests that the FDA declare that the drug product, Ergotamine Tartrate Sublingual Tablets 1 mg is suitable for submission in an Abbreviated New Drug Application.

🏛 Food and Drug Administration (FDA)FDA-2026-P-7182
Documents
6
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 6Supporting & Related Material 4Other 2
📄 Primary document
OtherJun 29, 2026
Suitability Petition from Senores Pharmaceuticals, Inc.
No comment period
Open →